The Role of FGL2 in the Pathogenesis and Treatment of Hepatitis C Virus Infection [0.03%]
FGL2在丙型肝炎病毒感染发病及治疗中的作用
Itay Shalev,Nazia Selzner,Ahmed Helmy et al.
Itay Shalev et al.
Chronic hepatitis C virus (HCV) infection is a leading cause of liver disease worldwide and remains the most common indication for liver transplantation. The current standard of care leads to a sustained viral response of roughly 50% of tre...
Pharmacology of Rasagiline, a New MAO-B Inhibitor Drug for the Treatment of Parkinson's Disease with Neuroprotective Potential [0.03%]
索拉吉林的药理作用：一种新的治疗帕金森病并有神经保护潜力的MAO-B抑制剂药物
John P M Finberg
John P M Finberg
Rasagiline (Azilect) is a highly selective and potent propargylamine inhibitor of monoamine oxidase (MAO) type B. Like other similar propargylamine inhibitors, rasagiline binds covalently to the N5 nitrogen of the flavin residue of MAO, res...
Fred Rosner
Fred Rosner
Avram Hershko
Avram Hershko
Shraga Blazer
Shraga Blazer